Concepedia

Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in Glioblastoma

Johannes Wach, Stefanos Apallas, Matthias Schneider, Johannes Weller, Patrick Schuss, Hartmut Vatter, Ulrich Herrlinger, Erdem Güresir

Frontiers in Oncology · 2021 · 13 citations · 39 references

DOIFull text

Open access

Abstract

MPV/PC ratio may independently predict the progression-free survival rates of patients with glioblastoma multiforme.

References

39

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

Quinn T. Ostrom, Haley Gittleman, P Farah et al. · Neuro-Oncology · 2013 · 12.1K citations · Full text

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.7K citations

, , +8

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.1K citations · Full text

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

Brain Pathology · 2009 · 4K citations · Full text

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

Michel Lacroix, Dima Abi-Said, Daryl R. Fourney et al. · Journal of neurosurgery · 2001 · 3K citations